Top segments and regional performance

Last year, the company generated ‪6.24 B‬ DKK, the most of which — ‪6.24 B‬ DKK — came from its top-performing segment, Life-Saving Vaccines, compared to ‪5.72 B‬ DKK the previous year. The greatest contribution came from United States, which accounted for ‪2.70 B‬ DKK last year, with ‪2.70 B‬ DKK the year before.